TAMMY MALONEY: Open Payments
NPI 1689617102 · NORFOLK, VA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$874 in 8 payments from 8 companies in 2025. Trend: 2023 $445 · 2024 $246 · 2025 $874
Food & beverage: $874
| Company | Payments | Amount |
|---|---|---|
| Averitas Pharma Inc. | 1 | $150 |
| GlaxoSmithKline, LLC. | 1 | $125 |
| KYOWA KIRIN, INC. | 1 | $125 |
| Eisai Inc. | 1 | $120 |
| Phathom Pharmaceuticals, Inc. | 1 | $119 |
| AstraZeneca Pharmaceuticals LP | 1 | $113 |
| Otsuka Pharmaceutical Development & Commercialization, Inc. | 1 | $98 |
| Grifols USA, LLC | 1 | $24 |
Products named: QUTENZA, AREXVY, Leqembi, VOQUEZNA, WAINUA, Prolastin-C Liquid.
Industry payments across VA — which companies pay providers there.
